On 8 March 2021 Kvika banki hf. („the Company“) announced that the Board of Directors had exercised its authority according to Temporary Provision IV of the Company‘s Articles of Association to increase its share capital by ISK 4,000,000 for the purpose of fulfilling the exercising of subscription rights.The share capital increase has now been registered by the register of undertakings of the Directorate of Internal Revenue and the share capital amounts to nominal value of ISK 2,186,717,495.It has been requested that the new shares will be issued by the Nasdaq central securities depository and that the shares will be listed for trading on the Main Market of Nasdaq Iceland.
Dublin, March 09, 2021 (GLOBE NEWSWIRE) -- The "Global Urology Devices Market by Product ([Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System], [Guidewires, Catheters, Stents]), Application (Kidney Diseases, Urological Cancer, BPH), End-user (Hospital, Dialysis Center, Homecare), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global urology devices market is projected to reach USD 46,408.2 million by 2026 from USD 38,005.6 million in 2021, at a CAGR of 4.1%. Market growth is driven by factors such as the growing number of hospitals and investments in endoscopy and laparoscopy facilities, rising incidence and prevalence of urological conditions, and growing preference for minimally invasive procedures. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years. The consumables & accessories segment accounted for the highest growth rate in the urology devices market, by product, during the forecast period The urology devices market is segmented into instruments and consumables & accessories based on product. In 2020, the consumables & accessories segment accounted for the highest growth rate in the urology devices market. The requirement of consumables and accessories in large numbers as compared to instruments is the major factor contributing to the growth of this segment. Urological cancer and BPH segment accounted for the highest CAGR Based on applications, the urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. The rising geriatric population and rising incidence of urological cancers are the major factors driving this segment's growth. Dialysis centers segment accounted for the highest CAGR Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the dialysis centers segment accounted for the highest growth rate. This can be attributed to the increased demand for advanced dialysis products and facilities for ESRD treatment. Asia-Pacific: The fastest-growing region urology devices market The global urology devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, increasing prevalence of diabetes, high burden of kidney diseases such as CKD, increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets are driving the growth of the urology devices market in this region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Urology Devices Market Overview4.2 Urology Instruments Market, by Type, 2021 vs. 2026 (USD Million)4.3 Urology Endoscopes Market, by Type, 2021 vs. 2026 (USD Million)4.4 Urology Devices Market Share, by End-user, 2021 vs. 20264.5 Urology Devices Market: Geographic Growth Opportunities 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers184.108.40.206 Rising Incidence and Prevalence of Urological Conditions220.127.116.11 Growing Preference for Minimally Invasive Procedures18.104.22.168 Growing Number of Hospitals and Investments in Endoscopy and Laparoscopy Facilities5.2.2 Restraints22.214.171.124 High Degree of Consolidation126.96.36.199 High Cost of Urology Devices5.2.3 Opportunities188.8.131.52 Emerging Markets Offer Lucrative Opportunities5.3 Impact of COVID-19 on the Urology Devices Market5.4 Pricing Analysis5.5 Patent Analysis5.6 Value Chain Analysis5.7 Supply Chain Analysis5.8 Ecosystem Analysis of the Urology Devices Market5.9 Porter's Five Forces Analysis5.9.1 Threat of New Entrants5.9.2 Threat of Substitutes5.9.3 Bargaining Power of Buyers5.9.4 Bargaining Power of Suppliers5.9.5 Intensity of Competitive Rivalry5.10 PESTLE Analysis5.11 Regulatory Landscape5.11.1 North America184.108.40.206 US220.127.116.11 Canada5.11.2 Europe5.11.3 Asia-Pacific18.104.22.168 China22.214.171.124 Japan126.96.36.199 India188.8.131.52 South Korea5.11.4 Latin America184.108.40.206 Brazil220.127.116.11 Mexico5.11.5 Middle East5.11.6 Africa5.12 Trade Analysis5.12.1 Trade Analysis for Dialysis Instruments18.104.22.168 Import Data for Dialysis Instruments, by Country, 2016-2020 (USD Million)5.12.2 Trade Analysis for Endoscopes22.214.171.124 Import Data for Endoscopes, by Country, 2016-2020 (USD Million) 6 Urology Devices Market, by Product6.1 Introduction6.2 Instruments6.2.1 Dialysis Devices126.96.36.199 Hemodialysis Devices188.8.131.52.1 HHD Has Gained Significance due to Improved Clinical Outcomes for Patients184.108.40.206 Peritoneal Dialysis Devices220.127.116.11.1 Technological Advancements in Pd Devices and Increasing Product Approvals to Propel Market Growth6.2.2 Endoscopes18.104.22.168 Laparoscopes22.214.171.124.1 Growing Number of Laparoscopy Procedures to Support the Market Growth126.96.36.199 Ureteroscopes188.8.131.52.1 Continuous Technological Advancements to Support the Growth of this Market184.108.40.206 Nephroscopes220.127.116.11.1 High Cost of Maintenance to Restrain the Market Growth18.104.22.168 Resectoscopes22.214.171.124.1 High Prevalence of Prostate, Kidney, and Bladder Cancers to Drive the Demand for Resectoscopes126.96.36.199 Cystoscopes188.8.131.52.1 Increasing Prevalence and Incidence of Urological Cancers to Drive the Uptake to Cystoscopes for Early Diagnosis and Treatment6.2.3 Laser & Lithotripsy Devices184.108.40.206 Increasing Prevalence of Kidney Diseases to Support Market Growth6.2.4 Endovision & Imaging Systems220.127.116.11 Need for High-Resolution Images for Better Observation of Body Cavities and Organs to Propel the Market in the Coming Years6.2.5 Robotic Systems18.104.22.168 Growing Industry-Academia Collaborations to Support Market Growth6.2.6 Insufflators22.214.171.124 Increasing Volume of Laparoscopic Procedures to Boost the Demand for Insufflators6.2.7 Endoscopy Fluid Management Systems126.96.36.199 Growing Incidence of Chronic Diseases to Drive the Market Growth6.2.8 Urodynamic Systems188.8.131.52 Growing Patient Pool to Support the Growth of this Product Segment6.3 Consumables & Accessories6.3.1 Dialysis Consumables184.108.40.206 Growing Number of Dialysis Procedures to Support Market Growth6.3.2 Catheters220.127.116.11 High Prevalence of Urinary Incontinence Will Drive the Market for Catheters6.3.3 Guidewires18.104.22.168 Development of Next-Generation Hybrid Guidewires Has Created Significant Growth Opportunities6.3.4 Retrieval Devices & Extractors22.214.171.124 Technological Advancements to Support Market Growth6.3.5 Surgical Dissectors, Forceps, & Needle Holders126.96.36.199 Growing Number of Urology Procedures to Support Market Growth6.3.6 Dilator Sets & Urethral Access Sheaths188.8.131.52 Growing Demand for Effective Endoscopic Management of Ureteral and Renal Calculi to Support Market Growth6.3.7 Stents184.108.40.206 Growing Prevalence of Urological and Kidney-Related Disorders to Propel Market Growth6.3.8 Biopsy Devices220.127.116.11 High Incidence of Prostate Cancer to Drive the Uptake of Biopsy Devices6.3.9 Tubes & Distal Attachments18.104.22.168 Growing Demand for Endoscopy is Expected to Propel the Growth of this Segment6.3.10 Drainage Bags22.214.171.124 Risk of Urinary Tract Infections and Skin Irritation to Restrain the Market Growth6.3.11 Other Consumables & Accessories 7 Urology Devices Market, by Application7.1 Introduction7.2 Kidney Diseases7.2.1 Growing Prevalence of Diabetes and Hypertension to Support Market Growth7.3 Urological Cancer & BPH7.3.1 Rising Preference for Minimally Invasive Procedures to Drive the Market Growth7.4 Pelvic Organ Prolapse7.4.1 High Costs Involved in Surgeries & High Reoccurrence Rates to Restrain the Market Growth7.5 Other Applications 8 Urology Devices Market, by End-user8.1 Introduction8.2 Hospitals, ASCs, & Clinics8.2.1 Hospitals, ASCs, & Clinics are the Largest End-users of Urology Devices8.3 Dialysis Centers8.3.1 Changing Reimbursement Policies in Developed Countries to Restrain the Market Growth8.4 Home Care Settings8.4.1 Improved Patient Outcomes and Shorter Hospital Stays to Support Market Growth 9 Urology Devices Market, by Region9.1 Introduction9.2 North America9.3 Europe9.4 Asia-Pacific9.5 Latin America9.6 Middle East & Africa 10 Competitive Landscape10.1 Overview10.2 Key Player Strategies10.3 Market Share Analysis10.4 Company Evaluation Quadrant10.4.1 List of Evaluated Vendors10.4.2 Stars10.4.3 Emerging Leaders10.4.4 Pervasive Players10.4.5 Participants10.5 Competitive Leadership Mapping for Startups (2019)10.5.1 Progressive Companies10.5.2 Starting Blocks10.5.3 Responsive Companies10.5.4 Dynamic Companies10.6 Competitive Scenario10.6.1 Market Evaluation Framework, 2018-202010.6.2 Product Launches & Approvals10.6.3 Expansions10.6.4 Acquisitions10.6.5 Partnerships, Collaborations, & Joint Ventures 11 Company Profiles11.1 Key Players11.1.1 Fresenius Medical Care AG & Co. KGaA11.1.2 Baxter International, Inc.11.1.3 Boston Scientific Corporation11.1.4 Becton, Dickinson and Company11.1.5 Olympus Corporation11.1.6 B. Braun Melsungen AG11.1.7 Stryker Corporation11.1.8 Intuitive Surgical11.1.9 Medtronic plc11.1.10 Cardinal Health11.2 Other Players11.2.1 Teleflex Incorporated11.2.2 Karl Storz11.2.3 Cook Medical11.2.4 Richard Wolf GmbH11.2.5 Compactcath11.2.6 Dornier Medtech11.2.7 Nikkiso Co. Ltd.11.2.8 Dialife SA11.2.9 Maxer Endoscopy GmbH11.2.10 Well Lead Medical Co. Ltd.11.2.11 Rocamed11.2.12 Endomed Systems GmbH11.2.13 Amsino International, Inc.11.2.14 Medispec11.2.15 Medical Technologies of Georgia11.2.16 Vimex Sp. Z O.O.11.2.17 Balton Sp. Z O.O.11.2.18 Hunter Urology11.2.19 Ribbel International Limited11.2.20 J & M Urinary Catheters, LLC 12 Appendix12.1 Insights from Industry Experts12.2 Discussion Guide12.3 Knowledge Store: The Subscription Portal12.4 Available Customizations For more information about this report visit https://www.researchandmarkets.com/r/xreqni CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Mental health charity Mind says it is "disappointed" by comments Piers Morgan made on Monday.